Stockreport

Alnylam Pharmaceuticals: Challenges In The TTR Space And Few Late-Stage Catalysts Are A Concern [Seeking Alpha]

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF ALNY's TTR franchise outperformed rivals in Q3, but prescription growth and competitive pricing dynamics remain key investor watchpoints. Competition is intensifying, [Read more]